# EDARAVONE
> **NDA221059** · New Drug Application · Sponsor: AZURITY PHARMACEUTICALS INC · Approved 2026-07-17
## Drug
- **FDA Application Number:** NDA221059
- **Application type:** New Drug Application
- **Brand name:** EDARAVONE
- **Generic name:** Edaravone
- **Active ingredients:** EDARAVONE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AZURITY PHARMACEUTICALS INC
- **First approval:** 2026-07-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=221059)
---
*MORVS · CC0 1.0*